Base4's drug discovery platform allows its collaborators to evaluate billions of novel small molecules to identify and progress RNA-modulators for important diseases
The company has raised US$4.5 million in funding for its AI operating system
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Advancing to IND-enabling studies with multiple drug candidates
The facility is among 12 centres established worldwide, and the first in Asia
It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies
The goal for the project is the identification and optimization of anti-viral compounds.
Subscribe To Our Newsletter & Stay Updated
